This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
treatment
Click here for Vydura®▼ (rimegepant) Prescribing Information for Great Britain and Northern Ireland.
Adverse event reporting information can be found at the bottom of the page.
All patient cases, images and quotations are fictional. They are intended as examples of cases you may encounter in clinical practice.
The guidance and suggestions provided are not intended to substitute a clinician's own experience, expertise and professional judgement.
Optimising treatment plans can be challenging in a condition that varies substantially between individuals, and in the same individual over time. Many factors influence choice of treatment and should be taken into account for both initiating and reviewing treatment.3
Patient preference
Family planning, pregnancy and breastfeeding
Frequency and severity of attacks
Type and severity of associated symptoms
Migraine-related disability
Prior treatment response
Comorbidities
Body habitus and physiological measurements
Use of concomitant medications
References
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd.
Pfizer accepts no responsibility for the content or services of the linked site.
PP-PFE-GBR-3858. November 2021
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd.
Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to Pfizer medicines or
business which it has provided or reviewed.
PP-PFE-GBR-3859. November 2021